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Objective: To determine whether infrainguinaI bypass urgery is worthwhile in patients with critical limb ischaemia 
(CLI) and chronic renal failure. 
Design: Longitudinal observational study. 
Materials and Methods: Twenty-two patients with moderate renal failure indicated by serum creatinine level above 
1501~molfl, 10 patients with end-stage renal disease requiring dialysis, and three patients with functioning kidney 
transplant, underwent 39 bypass procedures for critical limb ischaemia. 
Results: Six femoropopliteal, 14 femorocrural and 19 femoropedal bypasses were performed. The immediate, 1-month, 
and 1-year primary patency rates were 97%, 84%, and 70%, respectively. The limb salvage was 93% at 1-month and 
72% at 1-year follow-up. One-year patency and leg salvage rates were 81% and 79% in non-dialysis patients, and 47% 
and 37% in dialysis patients. At 1-year follow-up, 55% of surviving patients had salvaged limbs. None of the patients 
in dialysis was alive with salvaged legs 4 months after revascutarisation. Among preoperative risk factors, only serum 
creatinine showed a statistical significance in predicting leg salvage and survival. 
Conclusions: As the outcome of patients on dialysis is very poor after infrainguinal bypass grafting, revascularisation 
is seldom indicated. On the contrary, leg salvage can achieve good results in patients not requiring dialysis. 
Key Words: Femorodistal bypass; Critical limb ischaemia; Amputation; Chronic renal failure; Uraemia; Dialysis. 
Introduction 
The cardiovascular mortality rate in patients with end- 
stage renal disease requiring dialysis is approximately 
three times that of the age-matched controls. 1 In this 
patient population, the risk for silent myocardial in- 
farction and fatal cardiac arrhythmia is increased by 
diabetes 2'3 and surgery may further increase the mor- 
bidity and mortality as much as six times. 4The results 
of surgical treatment of atherosclerotic complications 
in patients with end-stage renal disease (ESRD) are 
known to be dismal compared to patients with normal 
renal function. ~6 Several metabolic and comorbid fac- 
tors have been proposed both for the development of
atherosclerosis and poor surgical outcome of patients 
with end-stage renal disease, r but the causes are still 
obscure. It has been shown that postoperative mor- 
bidity and mortality are also increased in patients with 
lesser degrees of chronic renal failure not yet requiring 
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dialysis who require arterial reconstructive procedures 
for lower limb ischaemia, s'9 As unreconstructed critical 
leg ischaemia (CLI) seems to predict a very poor 
outcome, 1°we have attempted to save legs, whenever 
it was feasible, in patients with all degrees of chronic 
renal insufficiency presenting to our institution with 
CLI. We describe the results of our experience in 35 
consecutive patients, with a special reference to cal- 
cium and phosphorus metabolic aberrations which 
have been claimed to be potential factors for the de- 
velopment of both vascular disease and wound com- 
plications. 11,12 
Materials and Methods 
Between January 1991 and December 1995, 35 con- 
secutive patients with chronic renal failure underwent 
39 infrainguinal bypass procedures for 36 critically 
ischaemic legs. Patient characteristics and risk factors 
are shown in Table 1. Twenty-two patients had mod- 
erate renal failure, as defined by a serum creatinine 
level exceeding 150 gmol/1 (normal value: 55-115 ~tmol/ 
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Table 1. Patients' characteristics and preoperative risk factors. 
Moderate renal Dialysis Transplanted 
failure 
No. of patients 22 10 3 
Sex M/F 11/11 5/5 2/1 
Mean age (range) 74 (62-84) 60 (37-69) 52 (46-59) 
Fountaine III/IV 2/21 1/9 3/0 
Diabetes 18 (82%) 7 (70%) 1 (33%) 
Smoking 3 (14%) - 2 (67%) 
Hypertension 15 (69%) 3 (30%) 1 (33%) 
CAD 17 (77%) 4 (40%) 1 (33%) 
CVD 5 (22%) 1 (10%) - 
Previous vascular surgery 10 (45%) 3 (30%) 2 (67%) 
Mean preoperative 
Creatinine l vel (range)* 238 (156-778) 783 (353-991) 261 (98-489) 
CAD: coronary artery disease; CVD: cerebrovascular disease. *Normal value: 55-115 gmol/1. 
1) not requiring dialysis. Ten patients had ESRD re- 
quiring long-term dialysis and three patients had a 
functioning kidney transplant. Eighty-two per cent, 
70% and 33% had diabetes, respectively. Critical limb 
ischaemia was presented as tissue loss in 30 legs 
and rest pain in six legs. Preoperative blood pressure 
measurements were obtained in all but four patients. 
We were not able to measure the toe systolic pressure 
in five patients because of previous toe amputation or 
ulcer. According to the European Working Group on 
Critical Leg Ischaemia, is an ankle systolic pressure of 
< 50 mmHg or a toe systolic pressure of < 30 mmHg 
was observed in 22 legs. Of these, 17 patients had 
diabetes. Patients underwent preoperative angio- 
graphy to evaluate the extent of arterial disease and 
to choose the appropriate inflow and outflow vessel. 
The reconstructive operation was conducted under 
combined spinal and epidural anaesthesia. Intra- 
vascular volume loading was standardised and blood 
loss meticulously replaced. During the postoperative 
period, all patients were given 100-250 mg per day of 
acetylsalicylic acid. Vancomycin was used as antibiotic 
prophylaxis with dosage titrated according to the 
serum creatinine levels. Patients were followed-up 
closely until wound healing had been achieved. The 
patency of the reconstructed vessels was assessed 
every 3 months during the first year and every 6 
months therafter. The overall period of follow-up 
ranged from 1 to 64 months. Graft patency was de- 
termined by clinical pulse examination and Doppler 
ankle-brachial index improvement of 0.15 or more 
over preoperative values, and by standard duplex 
scan examination when indicated. Angiography was 
performed after non-invasive assessment whenever 
symptoms recurred or there was a suspicion of threat- 
ening graft failure. We reviewed preoperative serum 
levels of phosphorus and calcium in 28 patients and 
the long-term preoperative serum level measurements 
of intact parathyroid hormone in 15 patients who were 
followed-up for a mean period of 21.6 months (range, 
4-31 months). Analysis of data was facilitated by the 
use of a microcomputer database (SPSS for Windows). 
Life-table analysis of primary and secondary graft 
patency, limb salvage, and patient survival conformed 
to the guidelines established by the Ad Hoc Committee 
on Reporting Standards, Society for Vascular Surgery/ 
International Society for Cardiovascular Surgery. 14 The 
Kaplan-Meier method was used to estimate survival, 
graft patency and limb salvage. A Cox regression 
model was used to estimate the impact of variables on 
the clinical outcome. Survival functions, graft patency, 
and limb salvage were compared by the log rank test. 
The Chi-squared and Fistier's exact ests were used to 
analyse categorical data, and the Mann-Whitney U- 
Test was used to analyse continuous data. 
Results 
Six femoropopliteal, 14 femorocrural and 19 femoro- 
pedal bypasses were performed. Thirty-two bypasses 
used the autogenous vein, three were composite sa- 
phenous vein/PTFE and there were four PTFE bypass 
grafts in five patients with moderate renal failure. The 
postoperative surgical complication rate was 33% and 
there were no differences between the subgroups 
(Table 2). After 39 procedures, four patients with mod- 
erate renal insufficiency and one patient with ESRD 
died during the 30-day postoperative period (14%). 
The causes of death were myocardial infarction in four 
patients, and stroke in one patient. One patient with 
moderate renal insufficiency, one patient on dialysis 
and one patient with kidney transplant underwent 
reoperation because of graft occlusion (two patients) 
and haemorrhage (one patient). The mean hospital 
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Tab le  2.  Pos tperat ive  compl i ca t ions .  
Complications Total Moderate renal Dialysis Transplanted 
failure 
No. patients/operations 35/39 22/24 10/11 3/4 
Surgical complications 13 (33%) 9 (37%) 3 (27%) 1 (25%) 
Wound edge necrosis 5 (13%) 4 (17%) 1 (9%) 2 (50%) 
Deep infection 6 (15%) 4 (17%) 1 (9%) 1 (25%) 
Haematoma 2 (5%) - 1 (9%) 1 (25%) 
Seroma 1 (2%) - - 1 (25%) 
Graft occlusion 4 (10%) 1 (4%) 2 (18%) 1 (25%) 
Cardiac 8 (20%) 7 (29%) 1 (9%) - 
Cerebrovascular 2 (5%) 2 (8%) - - 
Respiratory 2 (5%) 2 (8%) - - 
Sepsis 2 (5%) 1 (4%) 1 (9%) - 
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Fig. 1. Cumulative leg salvage in dialysis and in non-dialysis ub- 
groups of patients. Censored cases means death, lost to follow-up 
or the end of follow-up. (-) Dialysis; ( l )  dialysis-censor; (---) non 
dialysis; (O) non dialysis-censored. 
stay after operation was 17 days (range 2-74 days). 
The overall immediate, 1-month, and 1-year primary 
patency rates were 97%, 84%, and 70%, respectively, 
while the overall limb salvage was 93% at 1-month 
and 72% at 1-year follow-up. The 1-year and 2-year 
survival rates were 56% and 42%, respectively. One- 
year leg salvage was 79% in non-dialysis patients, and 
37% in dialysis patients (p=0.14) (Fig. 1), and the 
corresponding difference in the 1-year patency rate 
was 81% of non-dialysis patients and 47% of dialysis 
patients (p = 0.07) (Fig. 2). The patient survival rate at 
1-year was 68% in non-dialysis patients and 10% in 
dialysis patients (p=0.01) (Fig. 3). Because of pro- 
gressive infection or gangrene, two revascularised 
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Fig. 2. Cumulative patency in dialysis and in non-dialysis subgroups 
of patients. Censored cases means death, amputation, lost to follow- 
up or the end of follow-up. Key as for Fig. 1. 
patients underwent major amputation during the 30- 
day postoperative period. One of these patients had a 
functioning graft. Two patients with a functioning 
renal transplant underwent major amputation whilst 
one patient had limb salvage 30 months after re- 
vascularisation. At 1-year follow-up, 55% of surviving 
patients had a salvaged limb (Table 3), but none of 
the patients on dialysis was alive with a salvaged leg 
4 months after revascularisation (Fig. 4). 
Among the risk factors evaluated by Cox regression 
model (Table 1), only preoperative serum creatinine 
was significant (p = 0.01) in predicting leg salvage (p = 
0.01) and survival (p=0.002) and the relative risk of 
amputation associated with this variable was 1.42/ 
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Fig. 3. Cumulative survival in dialysis and in non-dialysis subgroups 
of patients. Censored cases means lost to follow-up or the end of 
follow-up. Key as for Fig. 1. 
Fig. 4. Cumulative alive patients with legs in dialysis and in non- 
dialysis subgroups of patients. Censored cases means lost to follow- 
up, or the end of follow-up. Key as for Fig. 1. 
Table 3. Results of infrainguinal bypass operations for critical leg ischaemia in patients with chronic renal failure reported in the 
literature. 
Authors No. of Peroperative 2-year primary 2-year limb 2-year survival Alive with 
patients mortality patency salvage rate legs at 1 year 
(%) (%) (%) (%) (%) 
Edwards et al? (1988) 19 NS 
Harrington et al. 21 (1990) 39 8 
Chang et al? ° (1990) 24 6 
Sanchez et aL 2° (1991) 99 13 
Whittemore t al. 9 (1993) 56 11 
Lumsden et al. = (1994) 34 6 
Baele et al. 28 (1995) 44 9 
Johnson et al. 4 (1995) 53 10 
Simsir et al. 6 (1995) 52 13 
Present series 35 14 
85 76 18" NS 
68 91 47 NS 
90 83 NS NS 
NS 71 46 NS 
73 76 0* NS 
46 NS 58 NS 
63 52 52 NS 
68 57 38 NS 
- 67§ 72§ NS 
70§ 72§ 42 55 
§At 1 year; *At 3 years; NT=not  stated. 
100 pmol/1. We could not find any significant statistical 
correlation between this risk factor and patency, and no 
correlation was found between the degree of ischaemia 
and clinical outcome, probably because of the small 
number of patients with Fontaine III stage disease 
(17%). Seven of the patients checked for aberrations 
of calcium and phosphorus metabolism had high mean 
intact parathyroid hormone levels ranging from 
90.6 ng/1 to 488 ng/1 (normal values, 15-60 ng/1). The 
mean serum phosphorus level was high in all but three 
patients, ranging from 1.41mmol/1 to 2.97mmol/1 
(normal values, 0.80-1.40 mmol/1). All patients had 
had high serum phosphorus and parathyroid hormone 
levels. The mean serum calcium level was normal in 
all patients. We found a positive correlation between 
the mean phosphorus values and the mean para- 
thyroid hormone levels (Kendall's coefficient: 0.47; p = 
0.19). However, preoperative serum phosphorus (Cox 
regression model analysis: p=0.58) and parathyroid 
hormone (univariate analysis: p = 0.94) levels did not 
have significant impact on the outcome of patients. 
Discussion 
It is a common opinion that periodic podiatrist care 
for uraemic patients may prevent minor foot ulcers 
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from evolving into limb-threatening lesions. ~5 How- 
ever, since vascular disease is the main cause of the 
development of leg ulcers, local treatment is often 
ineffective and it seems justified to suggest that these 
patients hould be seen early on by a vascular surgeon. 
Many authors 44'16 believe that uraemic patients with 
leg ulcers and/or gangrene are more likely to have a 
worse outcome after revascularisation than those with 
intact skin. In fact, even if combined vascular re- 
construction and microvascular muscle flap transfer 
proved to achieve good limb salvage results in the 
management of patients with large ischaemic lesionsF 
these aggressive surgical approaches for CLI fail to 
result in limb salvage in patients with chronic renal 
failure. 4Our very poor surgical results in patients on 
dialysis with Fontaine IV stage disease confirm these 
observations, although we could not find any sig- 
nificant influence of the degree of ischaemia on the 
outcome of these patients. 
Johnson et al. 4 suggested that achieving higher limb 
salvage rates does not depend only on better selection 
of patients for revascularisation, but also on im- 
provements in the control of postoperative infections 
and wound healing. In this way, the results by Blank- 
steijn et al. s demonstrated that the use of deeply placed 
grafts in these patients may result in a postoperative 
infection rate similar to that in the general population. 
The use of angioscopically assisted in situ technique is 
may further reduce the incidence of postoperative 
infection by shortening surgical incisions. Despite any 
surgical improvement, a high incidence of surgical 
and medical postoperative complications, and failure 
in leg salvage attempts certainly continues to be a 
major problem. We do not know whether the lower 
blood pressure observed in dialysed patients or the 
presence of Certain metabolites affected the graft pat- 
ency. However, amputations despite patent, func- 
tioning bypass grafts 4'5'19-24 suggest hat factors other 
than surgical may interfere both in the development of 
atherosclerotic disease and processes of tissue healing. 
Non-surgical factors may be responsible for poor re- 
sults and the progression of the atherosclerotic disease 
reported even in patients with moderate renal in- 
sufficiency or a functioning kidney or kidney-pancreas 
transplant. 4,25 
Aberrations in calcium and phosphorus homeostasis 
have been suggested as one hypothesis for accelerated 
atherosclerosis in uraemic patients. The phenomenon 
of calciphylaxis observed in these subjects has been 
advocated as responsible for depositions of calcium 
in soft tissues and vessels resulting in the common 
radiological and intraoperative findings of cir- 
cumferentially calcified arteries. 26-2s As a result of these 
tissue changes we found falsely-elevated ankle pres- 
sure values in more than one-third of patients, because 
ankle arteries could not be properly compressed by 
occluding cuff due to mediasclerosis. 29 This calcifying 
process is also likely to be responsible for spon- 
taneously appearing wounds in patients with sec- 
ondary and tertiary hyperparathyroidism, 11'3°which 
underlines the importance of these metabolic factors 
in both development and healing of such wounds. The 
increased survival time after renal transplantation a d 
in long-term dialysis may explain a cumulative phe- 
nomenon of calciphylaxis and obliterative arterial 
disease. 3°'31 Triggering of vasospastic and platelet-ag- 
gregating effects of factors involved in calcium and 
phosphorus homeostasis may also contribute. 12Long- 
term measurements showed high serum level of phos- 
phorus and parathyroid hormone in most of our 
patients, suggesting a potential prolonged effect of 
these factors on the arterial wall. Statistical analysis of 
our retrospectively reviewed ata, however, did not 
disclose any significant impact of calcium and phos- 
phorus metabolism in both survival and surgical 
outcome of these patients. Increased level of homo- 
cysteinemia has also been shown to have an important 
role in accelerating the development of atherosclerosis 
in patients under the age of 50 32 as well as in patients 
with chronic renal failure. 33 
Difficulties with healing and an increased rate of 
infection still represent the main reasons for the high 
postperative morbidity, and mortality rates and limb 
salvage failure, reported after infrainguinal re- 
vascularisation. The reduced formation of granulation 
tissue in wounds of uraemic patients and the deficiency 
of collagen content when uraemia is associated with 
diabetes 34may be explained by the common coexisting 
hypoalbuminemia, malnutrition, anaemia, or main- 
tenance steroid therapy in these compromised patients. 
The high rates of postoperative infections may also 
be due to impaired immune function as lymphocyte 
abnormalities, depressed cell-mediated immunity, 
phagocytosis and chemotaxis by granulocytes have all 
been described. 35
As a result of poor surgical outcome and multiple 
and poorly understood biological and medical prob- 
lems, some authors 4-6'16 have advocated primary am- 
putation in uraemic patients with necrotic and septic 
lesions, reserving arterial bypass procedures only for 
patients with lesser degrees of ischaemic disease. Al- 
though the short life expectancy of this patient popu- 
lation is well known, not all authors hare this point 
of v iew 9'19-21'28 and support an aggressive approach to 
limb salvage. It is our opinion that the results of this 
aggressive policy could be more clearly measured by 
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the number of patients alive with viable legs than by 
patency or amputation rates alone, which may be 
too optimistic (Table 3). Our experience shows that 
although 55% of patients were alive with salvaged 
legs 1 year after surgery, none of them belonged to 
the subgroup of dialysis patients. 
In conclusion, as the outcome of patients on dialysis 
is very poor after infrainguinal bypass grafting, it is 
seldom indicated. Leg salvage operations can be car- 
ried out with good results in patients with renal failure 
not requiring dialysis or those with a functioning renal 
transplant. 
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